Position in CRNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,357,931
-$489,552 QoQ
Shares Held
116,460
-12.7% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 266 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. CRNX ranks #86 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in CRNX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,357,931 | 116,460 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,847,483 | 133,466 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $7,359,041 | 158,089 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $3,723,216 | 89,393 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,247,305 | 78,140 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,346,423 | 69,959 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $15,249,724 | 298,254 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $13,045,827 | 255,300 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,133,818 | 181,599 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,282,699 | 176,943 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $6,113,959 | 171,837 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,275,072 | 177,373 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $677,136 | 37,577 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $616,863 | 38,410 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $334,540 | 18,281 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $366,225 | 18,647 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $390,137 | 20,919 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $424,578 | 19,343 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,404,574 | 190,235 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $347,345 | 16,501 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $258,282 | 13,702 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||